about
PEGylated Adenoviruses: From Mice to MonkeysMicroRNA-regulated viral vectors for gene therapyFunctional characterisation of the WW minimal domain for delivering therapeutic proteins by adenovirus dodecahedronCombinatorial peptide libraries: mining for cell-binding peptides.Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.Peptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancerEfficient and directive generation of two distinct endoderm lineages from human ESCs and iPSCs by differentiation stage-specific SOX17 transduction.In vivo bioluminescence tumor imaging of RGD peptide-modified adenoviral vector encoding firefly luciferase reporter gene.Vascular damage and anti-angiogenic effects of tumor vessel-targeted adenovirus-mediated herpes simplex virus thymidine kinase gene.Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy.Tumor vascular targeted delivery of polymer-conjugated adenovirus vector for cancer gene therapyEnhancing the therapeutic efficacy of adenovirus in combination with biomaterials.Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancerMagnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells.Affinity thresholds for membrane fusion triggering by viral glycoproteinsGene therapy for gastric cancer: is it promising?Evading the immune response upon in vivo gene therapy with viral vectors.Gene therapy for type I glycogen storage diseasesAdenoviral gene therapy in gastric cancer: a review.Polarization of protective immunity induced by replication-incompetent adenovirus expressing glycoproteins of pseudorabies virus.DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice.Polymer-enhanced adenoviral transduction of CAR-negative bladder cancer cells.Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptorCoating with spermine-pullulan polymer enhances adenoviral transduction of mesenchymal stem cells.Engineered adenovirus serotypes for overcoming anti-vector immunity.Polymer-functionalized nanoparticles: from stealth viruses to biocompatible quantum dots.Noncovalently associated cell-penetrating peptides for gene delivery applications.Antitumor Efficacy of SLPI Promoter-Controlled Expression of Artificial microRNA Targeting EGFR in a Squamous Cell Carcinoma Cell Line.Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy.Preliminary evaluation of safety of conditionally replication adenovirus M4.Genetically modified adenoviral vector with the protein transduction domain of Tat improves gene transfer to CAR-deficient cells.A simple, lanthanide-based method to enhance the transduction efficiency of adenovirus vectors.Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon.Contributions of E1A to mouse adenovirus type 1 pathogenesis following intranasal inoculation.Ex-vivo evaluation of gene therapy vectors in human pancreatic (cancer) tissue slices.EGFR-Targeted Adenovirus Dendrimer Coating for Improved Systemic Delivery of the Theranostic NIS GeneSurface immobilization of hexa-histidine-tagged adeno-associated viral vectors for localized gene delivery.Improving gene transfer in human renal carcinoma cells: Utilization of adenovirus vectors containing chimeric type 5 and type 35 fiber proteins.Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis.
P2860
Q24635276-767A3161-F0FB-4B7B-B9EC-7FA741C5CB7DQ26745822-DA9679B8-154B-4C98-B7AC-18E673137AD5Q27318180-C7CFB8C5-7884-4BF2-B634-04250FE19CBAQ31144876-71E1C5B5-FF9D-42CC-B0EA-D5EFF61108C9Q33520512-CF458D42-12F8-4214-A34E-3C26A54DE4BAQ33584756-EDE54FAE-60EB-4452-8B6B-CF35BA392BB9Q33961501-9B84D5C1-DCDB-48C4-8819-87E2DE6402ACQ34194326-319C1B9F-3E3D-4996-ACC9-21DFEED3C23BQ34224929-9E0C1B34-A128-4658-8FB5-BE316A6356CCQ34443707-6C272E53-B662-4562-BFFB-ED8D39370E35Q35238254-DBD02FF8-92F4-4D0B-8466-367A4AEBFACDQ35624010-3FF2A589-817C-471A-B8B6-62EBEAE13D56Q35672866-CF00533B-15EA-4397-A629-E6ACA32ACF55Q35952192-C720FEAF-5B7D-4CD1-91AB-F1523B47DC8BQ36315685-2B5D7364-CDB9-44AB-981A-23A8B601B994Q36401504-A4DC0511-D905-4913-92CC-710C6A323FC1Q36644230-B2BC9ECE-A0AB-420D-A226-4B26B31671DCQ36789527-860E5E76-5F0D-4CC8-B2E3-13357B9AF1A7Q37054346-F7E171E6-3339-4D3D-A34E-B67CAD3FD367Q37185010-E99DB3ED-1CAF-4C11-937B-4308DF19D4C5Q37241434-9EECA1E9-BD11-499B-ACD3-7B3F45C3676EQ37376339-703A6BA2-EE00-4B68-833E-100D66AC9EE8Q37513318-86CE2FC6-DEA9-4544-8544-0C80734A454BQ37515684-6EE4026B-4301-49D2-933E-0E231E7B3CF1Q37567831-026069EF-3448-4D31-B4AF-9076FBC6490AQ37643742-1F601A8B-6189-47AB-AA03-00D17F96B19EQ38112173-BED37266-9DF9-490A-8F37-BE2E4754BC74Q38720608-E29E3FDB-FD50-432E-80B9-909955B91E03Q38769919-42DFA11C-F24A-4F58-BD3A-1215909DE66CQ39220073-5C4A2288-9A4E-4AD9-9A38-A30C851937F9Q39948164-A97A08B3-F409-48DE-89F7-80D756A07DFEQ40011736-494B6C29-349C-4428-9E50-237EEDA1C373Q40226617-5F122197-A577-4CBE-BEAA-9A4EDCA55100Q40234010-156AB1CD-5BC3-4A60-9901-F5C049AB6CB1Q41833348-B2405B88-B655-4B9D-BB3E-8345AFDDAD43Q41866984-CEADBBE3-F68C-45D0-8135-160F725C8DEEQ41941382-A1786517-AB6B-44C6-8F35-EC2D408698A1Q42326136-D203DADA-03AA-4104-B9BF-67C084671BB5Q45863838-B4AF1DDA-B415-422F-9048-526D41AB720DQ45887307-D9D6D11A-7B02-4B7E-B176-D0D8FE812195
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Targeted adenovirus vectors.
@ast
Targeted adenovirus vectors.
@en
type
label
Targeted adenovirus vectors.
@ast
Targeted adenovirus vectors.
@en
prefLabel
Targeted adenovirus vectors.
@ast
Targeted adenovirus vectors.
@en
P356
P1433
P1476
Targeted adenovirus vectors.
@en
P2093
Takao Hayakawa
P304
P356
10.1089/HUM.2004.15.1034
P577
2004-11-01T00:00:00Z